These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21216118)

  • 61. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
    Cooksley G
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
    [No Abstract]   [Full Text] [Related]  

  • 62. Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient.
    Johnson K; Sargent LA; Galizio C; Ubogu EE
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1110-4. PubMed ID: 19047844
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
    Berenguer J; González-García J; López-Aldeguer J; Von-Wichmann MA; Quereda C; Hernando A; Sanz J; Tural C; Ortega E; Mallolas J; Santos I; Miralles P; Montes ML; Bellón JM; Esteban H;
    J Antimicrob Chemother; 2009 Jun; 63(6):1256-63. PubMed ID: 19363085
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations.
    Shi M; Wang RS; Zhang H; Zhu YF; Han B; Zhang Y; Jin LJ; Yang ZJ; Xu YP
    J Antimicrob Chemother; 2006 Nov; 58(5):1031-5. PubMed ID: 16987866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interferon-alpha and lamivudine combination therapy of children with chronic hepatitis b infection who were interferon-alpha nonresponders.
    Saltik-Temizel IN; Koçak N; Demir H
    Pediatr Infect Dis J; 2004 May; 23(5):466-8. PubMed ID: 15131475
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
    Kozielewicz D; Zaleśna A; Dybowska D
    Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment options in chronic hepatitis B].
    Nitschmann S
    Internist (Berl); 2006 Mar; 47(3):308-9; discussion 309-10. PubMed ID: 16485097
    [No Abstract]   [Full Text] [Related]  

  • 69. Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B.
    ter Borg MJ; Janssen HL
    Ann Intern Med; 2005 Sep; 143(5):391; author reply 391-2. PubMed ID: 16144900
    [No Abstract]   [Full Text] [Related]  

  • 70. The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon.
    Cooksley G
    J Hepatol; 2003; 39 Suppl 1():S143-5. PubMed ID: 14708693
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of interferon-alpha2b on hearing.
    Kaygusuz I; Oztürk Kaygusuz T; Oztürk A; Kiliç SS; Karlidağ T; Keleş E; Yalçin S
    Int J Audiol; 2004 Sep; 43(8):438-41. PubMed ID: 15643736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients.
    Huang YW; Hu JT; Hu FC; Chang CJ; Chang HY; Kao JH; Yang SS; Chen DS
    Antivir Ther; 2013; 18(4):567-73. PubMed ID: 23072880
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pegylated interferon alpha-2B induced lupus in a patient with chronic hepatitis B virus infection: case report.
    Yilmaz S; Cimen KA
    Clin Rheumatol; 2009 Oct; 28(10):1241-3. PubMed ID: 19653058
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reversible bilateral ototoxicity in a patient with chronic hepatitis B during peginterferon alpha-2a treatment.
    Gozdas HT; Karabay O
    Indian J Pharmacol; 2015; 47(1):121-2. PubMed ID: 25821325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection.
    Atasoy N; Ustundag Y; Konuk N; Atik L
    Clin Neuropharmacol; 2004; 27(3):105-7. PubMed ID: 15190230
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The possible effect of human menopausal gonadotropin on the audio-vestibular system.
    Abdel-Salam M; Abdel-Naby Awad OG; El-Badry M; Ibrahim A; Ibrahiem MH
    Auris Nasus Larynx; 2018 Dec; 45(6):1166-1172. PubMed ID: 29747963
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A clinical study on leucogen tablets therapy efficacy during PEG-alpha interferon and alpha-interferon in chronic hepatitis B].
    Zhang HF; Wang LM; Dong Y; Xu ZQ; Chen DW; Gan Y; Wang FC; Zhu SS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):111-3. PubMed ID: 23002548
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of interferon-alpha and combination interferon-alpha and lamivudine therapy on height and weight in children with chronic hepatitis B infection.
    Kuloğlu Z; Kansu A; Demirçeken F; Arici ZS; Berberoğlu M; Ocal G; Girgin N
    J Pediatr Endocrinol Metab; 2007 May; 20(5):615-20. PubMed ID: 17642422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon.
    Hui AY; Chan HL; Cheung AY; Cooksley G; Sung JJ
    Aliment Pharmacol Ther; 2005 Sep; 22(6):519-28. PubMed ID: 16167968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report.
    Liu Y; Chen H; Xu ZY
    Medicine (Baltimore); 2023 Apr; 102(14):e33378. PubMed ID: 37026950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.